Initial Approach to Starting Antihypertensive Medication
For patients with hypertension, initial antihypertensive therapy should be based on blood pressure severity, with monotherapy for stage 1 hypertension and combination therapy for stage 2 hypertension or BP >20/10 mmHg above target. 1
Assessment of Hypertension Severity
- Confirm hypertension diagnosis with office BP ≥140/90 mmHg or home BP ≥135/85 mmHg or 24h ambulatory BP ≥130/80 mmHg 1
- Classify hypertension:
- Grade 1/Stage 1: 140-159/90-99 mmHg
- Grade 2/Stage 2: ≥160/100 mmHg
Initial Treatment Algorithm
Step 1: Lifestyle Modifications (for all patients)
- Sodium restriction (<1500 mg/day)
- Increased potassium intake (3500-5000 mg/day)
- Weight loss if overweight/obese
- Physical activity (90-150 min/week)
- Moderation of alcohol intake
- DASH diet (fruits, vegetables, whole grains, low-fat dairy) 1
Step 2: Pharmacological Therapy Based on BP Level
For Stage 1 Hypertension (140-159/90-99 mmHg):
- High-risk patients (CVD, CKD, diabetes, organ damage, or age 50-80): Start drug therapy immediately
- Low-risk patients: Trial of lifestyle modifications for 3-6 months, then start drug if BP remains elevated 1
- Initial drug choice: Single agent (monotherapy) 1
For Stage 2 Hypertension (≥160/100 mmHg) or BP >20/10 mmHg above target:
- Start drug therapy immediately alongside lifestyle modifications
- Initial drug choice: Two-drug combination therapy 1
Drug Selection Based on Patient Demographics
For Non-Black Patients:
- Start with low-dose ACE inhibitor (e.g., lisinopril 10 mg daily) 2 or ARB (e.g., losartan 50 mg daily) 3
- If BP not controlled, increase to full dose
- Add thiazide/thiazide-like diuretic (e.g., chlorthalidone 25 mg daily) 4
- If needed, add calcium channel blocker 1
For Black Patients:
- Start with low-dose ARB (e.g., losartan 50 mg daily) 3
- Add dihydropyridine calcium channel blocker or thiazide/thiazide-like diuretic
- Increase to full doses
- Add ACE inhibitor if needed 1
Special Considerations
- Elderly patients (>80 years) or frail: Consider monotherapy at lower starting doses with more gradual titration 1
- Patients with comorbidities: Drug selection should be tailored:
- Diabetes with albuminuria: Prefer ACE inhibitor or ARB
- Chronic kidney disease: Prefer ACE inhibitor or ARB
- Heart failure: Prefer ACE inhibitor/ARB, beta-blocker, and diuretic 1
Monitoring and Follow-up
- Monitor BP control within 3 months of starting therapy
- Target: Reduce BP by at least 20/10 mmHg; ideally to <140/90 mmHg
- Check electrolytes and renal function after starting ACE inhibitors, ARBs, or diuretics 1
Common Pitfalls to Avoid
- Therapeutic inertia: Failure to intensify treatment when BP remains uncontrolled
- Rapid BP reduction: Avoid excessive lowering in elderly patients, which may lead to orthostatic hypotension
- Inappropriate drug combinations: Avoid combining ACE inhibitors with ARBs
- Inadequate dosing: Ensure adequate dosing before adding additional agents 5
The evidence strongly supports a stepped-care approach for most patients, with initial monotherapy for stage 1 hypertension and combination therapy for stage 2 hypertension. This approach balances efficacy with minimizing side effects, which is crucial for long-term adherence and successful BP control.